Epidemiological Study to Assess the Prevalence of Lung Cancer in patients with smoking-associated atherosclerotic cardiovascular diseases: PREVALUNG study protocol.

David BoulateMarine FidelleCaroline CaramellaJustin IssardOlivier PlanchéPauline PradèreDaniel GarelikOcéane HacheLilia LamraniMarc ZinsHélène BeaussierGilles ChatellierElie FadelLaurence ZitvogelBenjamin BesseOlaf Mercier

Published in: BMJ open (2022)

NCT03976804.

Keyphrases

study protocol
cardiovascular disease
randomized controlled trial
risk factors
smoking cessation
clinical trial
open label
cardiovascular risk factors
type diabetes
double blind
placebo controlled